Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02974140 · ClinicalTrials.gov registry record · NA
Cataract Refractive Suite Study
A NA study, sponsored by Alcon, a Novartis Company.
- Terminated
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT02974140 is a NA study that was terminated before completion, run by Alcon, a Novartis Company. The registered enrollment target is 39 participants.
The verdict
NCT02974140, a NA study, was terminated before completion, sponsored by Alcon, a Novartis Company.
- TERMINATED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the refractive predictability (prediction error) between the Cataract Refractive Suite (CRS) and standard manual technique at one month post-operative
Interventions
- DEVICE Cataract Refractive Suite (CRS)
- PROCEDURE Standard manual technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2017-03-02 |
| Est. Completion | 2017-07-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02974140
The ClinicalTrials.gov registry entry for NCT02974140 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon, a Novartis Company, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cataract Refractive Suite (CRS) is the first listed.
NCT02974140 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02974140 about?
NCT02974140 is a clinical study titled "Cataract Refractive Suite Study". The purpose of this study is to compare the refractive predictability (prediction error) between the Cataract Refractive Suite (CRS) and standard manual technique at one month post-operative
What is the current status of trial NCT02974140?
This trial is currently terminated. It is a NA study. The enrollment target is 39 participants. The study started on 2017-03-02. Estimated completion is 2017-07-25.
What interventions are being tested in trial NCT02974140?
The interventions under investigation include: Cataract Refractive Suite (CRS) (DEVICE), Standard manual technique (PROCEDURE).
Who is sponsoring clinical trial NCT02974140?
This trial is sponsored by Alcon, a Novartis Company, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.